title: Letter by Replogle and Moore regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
authors.affiliation: Department of Family Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
authors.forename: William H
authors.initials: WH
authors.lastname: Replogle
authors.forename: Shannon Pittman
authors.initials: SP
authors.lastname: Moore
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011728:Pyridones / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D011720:Pyrazoles; D011728:Pyridones; D014859:Warfarin